DE69620220D1 - Antibakterielles mittel zur oralen verabreichung - Google Patents

Antibakterielles mittel zur oralen verabreichung

Info

Publication number
DE69620220D1
DE69620220D1 DE69620220T DE69620220T DE69620220D1 DE 69620220 D1 DE69620220 D1 DE 69620220D1 DE 69620220 T DE69620220 T DE 69620220T DE 69620220 T DE69620220 T DE 69620220T DE 69620220 D1 DE69620220 D1 DE 69620220D1
Authority
DE
Germany
Prior art keywords
oral administration
antibacterial agent
antibacterial
agent
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69620220T
Other languages
English (en)
Other versions
DE69620220T2 (de
Inventor
Kenichi Abe
Masato Ota
Hiroyuki Yamaguchi
Chikako Murakami
Toshihiro Kikkoji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Application granted granted Critical
Publication of DE69620220D1 publication Critical patent/DE69620220D1/de
Publication of DE69620220T2 publication Critical patent/DE69620220T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69620220T 1995-10-13 1996-10-14 Antibakterielles mittel zur oralen verabreichung Expired - Fee Related DE69620220T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26584795 1995-10-13
PCT/JP1996/002967 WO1997013516A1 (fr) 1995-10-13 1996-10-14 Composition antibacterienne administree par voie orale

Publications (2)

Publication Number Publication Date
DE69620220D1 true DE69620220D1 (de) 2002-05-02
DE69620220T2 DE69620220T2 (de) 2002-11-28

Family

ID=17422903

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69620220T Expired - Fee Related DE69620220T2 (de) 1995-10-13 1996-10-14 Antibakterielles mittel zur oralen verabreichung

Country Status (16)

Country Link
US (1) US5958915A (de)
EP (1) EP0862915B1 (de)
KR (1) KR100311576B1 (de)
CN (1) CN1102046C (de)
AR (1) AR004014A1 (de)
AT (1) ATE214930T1 (de)
BR (1) BR9610836A (de)
CA (1) CA2234426C (de)
DE (1) DE69620220T2 (de)
ES (1) ES2174109T3 (de)
HK (1) HK1016477A1 (de)
HU (1) HU224922B1 (de)
MX (1) MX9802849A (de)
PT (1) PT862915E (de)
TW (1) TW458778B (de)
WO (1) WO1997013516A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302082B6 (cs) * 1998-01-07 2010-09-29 Meiji Seika Kaisha Ltd. Prostredek zahrnující krystalograficky stabilní amorfní cefalosporin a zpusob jeho výroby
CZ303495B6 (cs) * 1998-11-02 2012-10-24 Elan Pharma International Limited Mnohocásticový modifikovane uvolnující prostredek a jeho použití, pevná orální dávkovací forma
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
AU2002224053A1 (en) * 2000-11-21 2002-06-03 Kyorin Pharmaceutical Co. Ltd. Dry syrup preparations
US7125565B2 (en) 2000-12-01 2006-10-24 Kyowa Hakko Kogyo Co., Ltd. Composition improved in the solubility or oral absorbability
US20030060451A1 (en) * 2001-05-29 2003-03-27 Rajneesh Taneja Enhancement of oral bioavailability of non-emulsified formulations of prodrug esters with lecithin
WO2002096354A2 (en) 2001-05-29 2002-12-05 Tap Pharmaceutical Products Inc. Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
AU2003235395A1 (en) * 2002-05-22 2003-12-02 Shionogi And Co., Ltd. Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water
AUPS303202A0 (en) * 2002-06-20 2002-07-11 Pacific Biolink Pty Limited Protein based oral lubricant
DE60334391D1 (de) * 2002-10-02 2010-11-11 Meiji Seika Kaisha Antibakterielle medizinische zusammensetzung mit erhöhtem oralem absorptionsvermögen
KR101178657B1 (ko) * 2003-10-08 2012-08-30 메이지 세이카 파루마 가부시키가이샤 세프디토렌 피복실을 함유하는 비결정질 항균 조성물
JP2005162696A (ja) * 2003-12-04 2005-06-23 Nichiko Pharmaceutical Co Ltd 溶出性に優れたセフジトレンピボキシル製剤
EP1819313B1 (de) 2004-11-16 2010-12-29 3M Innovative Properties Company Dentalfüllstoffe und zusammensetzungen mit phosphatsalzen
CN101098672B (zh) 2004-11-16 2012-10-10 3M创新有限公司 包括酪蛋白酸盐的牙科填料、方法和组合物
EP1811942B1 (de) 2004-11-16 2011-10-05 3M Innovative Properties Company Dentale zusammensetzungen mit calziumphosphor-freisetzendem glas
KR101366911B1 (ko) 2004-11-16 2014-02-24 쓰리엠 이노베이티브 프로퍼티즈 컴파니 인-함유 표면 처리제를 포함하는 치과용 충전제, 및 그의조성물 및 방법
WO2008073068A1 (en) 2005-06-08 2008-06-19 Elan Pharma International Limited Nanoparticulate and controlled release compositions comprising cefditoren
US20080069879A1 (en) * 2006-05-02 2008-03-20 Ravishekhar Bhiwgade Stable solid dosage form containing amorphous cefditoren pivoxil and process for preparation thereof
WO2010068359A1 (en) 2008-12-11 2010-06-17 3M Innovative Properties Company Surface-treated calcium phosphate particles suitable for oral care and dental compositions
TR201000688A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
WO2012010938A2 (en) * 2010-07-23 2012-01-26 Lupin Limited Pharmaceutical compositions of cefditoren pivoxil
WO2016114727A1 (en) 2015-01-16 2016-07-21 Öğün Yusuf Toktamiş Cefditoren pivoxil compositions with improved stability and production methods thereof
CN105663058A (zh) * 2016-02-01 2016-06-15 济南康和医药科技有限公司 一种头孢妥仑匹酯纳米粒药物制剂及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936609A (ja) * 1982-08-26 1984-02-28 Nitto Electric Ind Co Ltd 粘着性貼付製剤
JPS59184122A (ja) * 1983-03-31 1984-10-19 Nitto Electric Ind Co Ltd アクリル系膏体
JPS60102168A (ja) * 1983-11-08 1985-06-06 Tsukishima Shokuhin Kogyo Kk エイコサペンタエン酸強化乳化物及び食品の製造方法
IE58487B1 (en) * 1984-09-07 1993-09-22 Kaisha Maiji Seika New cephalosporin compounds and the production thereof
JPH0678234B2 (ja) * 1988-04-19 1994-10-05 明治製菓株式会社 経口投与用抗菌組成物
JPH0635394B2 (ja) * 1989-02-28 1994-05-11 雪印乳業株式会社 薬物の溶解性および吸収性の改善方法
JPH0717866A (ja) * 1993-06-16 1995-01-20 Meiji Seika Kaisha Ltd 医薬組成物
JPH0840907A (ja) * 1994-08-03 1996-02-13 Meiji Seika Kaisha Ltd セファロスポリン注射剤

Also Published As

Publication number Publication date
HK1016477A1 (en) 1999-11-05
MX9802849A (es) 1998-11-30
CA2234426A1 (en) 1997-04-17
HUP9900609A2 (hu) 1999-07-28
CN1102046C (zh) 2003-02-26
DE69620220T2 (de) 2002-11-28
ES2174109T3 (es) 2002-11-01
HUP9900609A3 (en) 2001-04-28
EP0862915A4 (de) 1998-11-11
EP0862915B1 (de) 2002-03-27
KR19990064137A (ko) 1999-07-26
TW458778B (en) 2001-10-11
WO1997013516A1 (fr) 1997-04-17
PT862915E (pt) 2002-09-30
EP0862915A1 (de) 1998-09-09
CN1202110A (zh) 1998-12-16
KR100311576B1 (ko) 2001-12-28
BR9610836A (pt) 1999-07-13
US5958915A (en) 1999-09-28
CA2234426C (en) 2003-07-08
AR004014A1 (es) 1998-09-30
ATE214930T1 (de) 2002-04-15
HU224922B1 (en) 2006-04-28

Similar Documents

Publication Publication Date Title
ATE214930T1 (de) Antibakterielles mittel zur oralen verabreichung
ATE206924T1 (de) Oral anzuwendende arzneizubereitung enthaltend olanzapin
DE69635993T8 (de) Gelierte arzneimittel zur oralen verabreichung
DK0936913T4 (da) Oralt farmaceutisk præparat indeholdende ibandronat
DE10199046I2 (de) Rapamycin-Zubereitungen zur oralen Verabreichung
DK0754061T3 (da) Ny oral farmaceutisk doseringsform
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
NO20021172D0 (no) Farmasöytisk sammensetning
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
DE69807768D1 (de) Rapamycin enthaltende Formulierungen zur oralen Verabreichung
LV11727A (lv) Farmaceitiska kompozicija
ATE283687T1 (de) Rapamycin-formulierungen zur oralen verabreichung
FI973280A (fi) Farmaseuttinen koostumus
FI973230A (fi) Uusi farmaseuttinen formulaatio
BR9605777A (pt) Composição farmacêutica
BR9605131A (pt) Composição farmacêutica
ATE239508T1 (de) Partikulare arzneiform
SE9502453D0 (sv) Drug formulations
KR970015941U (ko) 구두골
BR7501191U (pt) Conjunto de hastilhas para escova dental
SE9404467D0 (sv) Drug formulations
SE9402925D0 (sv) Novel oral pharmaceutical composition

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee